-
公开(公告)号:US5856529A
公开(公告)日:1999-01-05
申请号:US987478
申请日:1997-12-09
申请人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
发明人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
IPC分类号: C07D307/81 , A01N43/08 , A01N43/30 , A01N43/32 , A61K31/335 , A61K31/34 , A61K31/343 , A61K31/353 , A61K31/357 , A61K31/36 , A61P25/00 , A61P25/20 , A61P43/00 , C07D307/79 , C07D307/88 , C07D311/58 , C07D313/08 , C07D317/46 , C07D317/58 , C07D319/04 , C07D319/08 , C07D319/18 , C07D321/10 , C07D209/04 , C07D319/16 , C07D493/02
CPC分类号: C07D307/79 , C07D311/58 , C07D313/08 , C07D317/58 , C07D319/18 , C07D321/10 , Y02P20/582
摘要: Novel derivatives of benzofuran and dihydrobenzofuran are provided which are useful as melatonergic agents.
摘要翻译: 提供了苯并呋喃和二氢苯并呋喃的新型衍生物,其可用作褪黑激素试剂。
-
公开(公告)号:US6060506A
公开(公告)日:2000-05-09
申请号:US352560
申请日:1999-07-13
申请人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
发明人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
IPC分类号: C07D307/81 , A01N43/08 , A01N43/30 , A01N43/32 , A61K31/335 , A61K31/34 , A61K31/343 , A61K31/353 , A61K31/357 , A61K31/36 , A61P25/00 , A61P25/20 , A61P43/00 , C07D307/79 , C07D307/88 , C07D311/58 , C07D313/08 , C07D317/46 , C07D317/58 , C07D319/04 , C07D319/08 , C07D319/18 , C07D321/10 , A61K31/35 , C07D311/04
CPC分类号: C07D307/79 , C07D311/58 , C07D313/08 , C07D317/58 , C07D319/18 , C07D321/10 , Y02P20/582
摘要: Novel derivatives of benzopyran are provided which are useful as melatonergic agents.
摘要翻译: 提供了苯并吡喃的新型衍生物,其可用作褪黑激素试剂。
-
公开(公告)号:US5981571A
公开(公告)日:1999-11-09
申请号:US169784
申请日:1998-10-09
申请人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
发明人: John D. Catt , Graham Johnson , Daniel J. Keavy , Ronald J. Mattson , Michael F. Parker , Katherine S. Takaki , Joseph P. Yevich
IPC分类号: C07D307/81 , A01N43/08 , A01N43/30 , A01N43/32 , A61K31/335 , A61K31/34 , A61K31/343 , A61K31/353 , A61K31/357 , A61K31/36 , A61P25/00 , A61P25/20 , A61P43/00 , C07D307/79 , C07D307/88 , C07D311/58 , C07D313/08 , C07D317/46 , C07D317/58 , C07D319/04 , C07D319/08 , C07D319/18 , C07D321/10 , C07D317/60 , A61K31/35
CPC分类号: C07D307/79 , C07D311/58 , C07D313/08 , C07D317/58 , C07D319/18 , C07D321/10 , Y02P20/582
摘要: Novel derivatives of benzodioxa alkylene ethers are provided which are useful as melatonergic agents.
摘要翻译: 提供了苯并二氧杂环己烷基醚的新型衍生物,其可用作褪黑激素试剂。
-
4.
公开(公告)号:US5753709A
公开(公告)日:1998-05-19
申请号:US644087
申请日:1996-05-09
IPC分类号: C07C233/13 , C07C233/18 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07D213/30 , A61K31/16 , C07C233/05
CPC分类号: C07C233/18 , C07C233/13 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07D213/30 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14
摘要: Certain N-acyl 2-aryl cyclopropylmethylamine derivatives are useful as melatonergic agents.
摘要翻译: 某些N-酰基2-芳基环丙基甲胺衍生物可用作褪黑激素药。
-
公开(公告)号:US5596019A
公开(公告)日:1997-01-21
申请号:US487306
申请日:1995-06-07
IPC分类号: C07C233/13 , C07C233/18 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07D213/30 , A61K31/16 , C07C233/06
CPC分类号: C07D213/30 , C07C233/13 , C07C233/18 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14
摘要: Certain N-acyl-cycloalkylamine derivatives are useful as melatonergic agents.
摘要翻译: 某些N-酰基 - 环烷基胺衍生物可用作褪黑素能药剂。
-
6.
公开(公告)号:US5889031A
公开(公告)日:1999-03-30
申请号:US20884
申请日:1998-02-09
IPC分类号: C07C233/13 , C07C233/18 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07D213/30 , A61K31/44
CPC分类号: C07C233/18 , C07C233/13 , C07C233/60 , C07C235/08 , C07C255/60 , C07C275/24 , C07C275/26 , C07C323/60 , C07D213/30 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14
摘要: Certain N-acyl 2-aryl cyclopropylmethylamine derivatives are useful as melatonergic agents.
摘要翻译: 某些N-酰基2-芳基环丙基甲胺衍生物可用作褪黑激素药。
-
公开(公告)号:US5661185A
公开(公告)日:1997-08-26
申请号:US572838
申请日:1995-12-14
申请人: Katherine S. Takaki , George N. Karageorge , Daniel J. Keavy , Michael F. Parker , Brett T. Watson
发明人: Katherine S. Takaki , George N. Karageorge , Daniel J. Keavy , Michael F. Parker , Brett T. Watson
IPC分类号: C07C233/18 , C07C233/20 , C07C233/60 , C07C235/08 , C07C275/24 , A61K31/17 , C07C275/06
CPC分类号: C07C233/60 , C07C233/18 , C07C233/20 , C07C235/08 , C07C275/24 , C07C2101/02 , C07C2101/04 , C07C2101/08 , Y10S514/923
摘要: New melatonergic agents are phenyl alkanyl or phenyl alkyl substituted carboxamides and ureas of Formula I: ##STR1## wherein: R.sub.1 =C.sub.1-3 alkyl, allyl, C.sub.3-6 cycloalkyl substituted C.sub.1-4 alkyl;R.sub.2 =hydrogen, halogen or C.sub.1-4 alkoxy;R.sub.3 =hydrogen or C.sub.1-4 alkyl;R.sub.4 =C.sub.1-4 alkyl, C.sub.1-4 alkyl substituted amino, carboxylic acid substitutedC.sub.1-4 alkyl or C.sub.3-6 cycloalkyl, C.sub.3-6 cycloalkyl, or straight or branched chainC.sub.2-4 alkenyl;A=a linear C.sub.2-4 alkanediyl or alkenediyl chain, provided that A not be --CH.sub.2 CH.sub.2 -- when X is a bond; andX=a covalent bond or oxygen.
摘要翻译: 新的褪黑激素剂是式I的苯基烷基或苯基烷基取代的甲酰胺和脲:其中:R 1 = C 1-3烷基,烯丙基,C 3-6环烷基取代的C 1-4烷基; R2 =氢,卤素或C1-4烷氧基; R3 =氢或C1-4烷基; R 4 = C 1-4烷基,C 1-4烷基取代的氨基,羧酸取代的C 1-4烷基或C 3-6环烷基,C 3-6环烷基或直链或支链C 2-4链烯基; A =直链C 2-4烷二基或亚烯基链,条件是当X为键时A不为-CH 2 CH 2 - X =共价键或氧。
-
公开(公告)号:US5541228A
公开(公告)日:1996-07-30
申请号:US376328
申请日:1995-03-08
申请人: Katherine S, Takaki , George N. Karageorge , Daniel J. Keavy , Michael F. Parker , Brett T. Watson
发明人: Katherine S, Takaki , George N. Karageorge , Daniel J. Keavy , Michael F. Parker , Brett T. Watson
IPC分类号: A61K31/165 , A61P5/00 , A61P13/02 , A61P15/00 , A61P25/20 , A61P25/24 , A61P25/26 , A61P27/02 , A61P35/00 , A61P37/00 , C07C233/18 , C07C233/19 , C07C233/20 , C07C233/60 , C07C235/08 , C07C275/24 , A61K31/16 , C07C233/05
CPC分类号: C07C233/20 , C07C233/18 , C07C233/60 , C07C235/08 , C07C275/24 , C07C2101/02 , C07C2101/04 , C07C2101/08
摘要: New melatonergic agents are phenyl alkanyl or phenyl alkyl substituted carboxamides and ureas of Formula I: ##STR1## wherein: R.sub.1 =C.sub.1-3 alkyl, allyl, C.sub.3-6 cycloalkyl substituted C.sub.1-4 alkyl;R.sub.2 =hydrogen, halogen or C.sub.1-4 alkoxy;R.sub.3 =hydrogen or C.sub.1-4 alkyl;R.sub.4 =C.sub.1-4 alkyl, C.sub.1-4 alkyl substituted amino, carboxylic acid substitutedC.sub.1-4 alkyl or C.sub.3-6 cycloalkyl, C.sub.3-6 cycloalkyl, or straight or branched chain C.sub.2-4 alkenyl;A=a linear C.sub.2-4 alkanediyl or alkenediyl chain, provided that A not be --CH.sub.2 CH.sub.2 -- when X is a bond; andX=a covalent bond or oxygen.
摘要翻译: 新的褪黑激素剂是式I的苯基烷基或苯基烷基取代的甲酰胺和脲:其中:R 1 = C 1-3烷基,烯丙基,C 3-6环烷基取代的C 1-4烷基; R2 =氢,卤素或C1-4烷氧基; R3 =氢或C1-4烷基; R 4 = C 1-4烷基,C 1-4烷基取代的氨基,羧酸取代的C 1-4烷基或C 3-6环烷基,C 3-6环烷基或直链或支链C 2-4链烯基; A =直链C 2-4烷二基或亚烯基链,条件是当X为键时A不为-CH 2 CH 2 - X =共价键或氧。
-
公开(公告)号:US06967196B1
公开(公告)日:2005-11-22
申请号:US09890927
申请日:2000-02-22
申请人: David W. Smith , Benito Munoz , Kumar Srinivasan , Carl P. Bergstrom , Prasad V. Chaturvedula , Milind S. Deshpande , Daniel J. Keavy , Wai Yu Lau , Michael F. Parker , Charles P. Sloan , Owen B. Wallace , Henry Hui Wang
发明人: David W. Smith , Benito Munoz , Kumar Srinivasan , Carl P. Bergstrom , Prasad V. Chaturvedula , Milind S. Deshpande , Daniel J. Keavy , Wai Yu Lau , Michael F. Parker , Charles P. Sloan , Owen B. Wallace , Henry Hui Wang
IPC分类号: A61K31/40 , A61K31/407 , A61K31/47 , A61K31/4965 , A61K31/54 , A61P25/00 , C07C311/21 , C07C323/41
CPC分类号: C07D285/06 , C07C311/21 , C07C323/41 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2602/42 , C07C2603/74 , C07D205/04 , C07D207/08 , C07D207/12 , C07D207/20 , C07D207/48 , C07D211/22 , C07D211/24 , C07D211/46 , C07D211/70 , C07D213/30 , C07D213/76 , C07D217/04 , C07D233/61 , C07D277/06 , C07D277/46 , C07D295/088 , C07D295/12 , C07D295/205 , C07D311/20 , C07D333/48 , C07D491/10
摘要: In accordance with the present invention, there is provided a novel class of sulfonamide compounds. Compounds of the invention contain a core sulfonamide group. Variable moieties connected to the sulfur atom and nitrogen atom of the sulfonamide group include substituted or unsubstituted hydrocarbyl moieties, substituted or unsubstituted heterocycle moieties, polycyclic moieties, halogen, alkoxy, ether, ester, amide, sulfonyl, sulfonamidyl, sulfide, carbamate, and the like. Invention compounds are capable of a wide variety of uses. For example sulfonamide compounds can act to modulate production of amyloid β protein and are useful in the prevention or treatment of a variety of diseases. Pharmaceutical compositions containing invention compounds are also provided. Such compositions have wide utility for the prevention or treatment of a variety of diseases.
摘要翻译: 根据本发明,提供了一类新型的磺酰胺化合物。 本发明的化合物含有核心磺酰胺基团。 连接到磺酰胺基团的硫原子和氮原子的可变部分包括取代或未取代的烃基部分,取代或未取代的杂环部分,多环部分,卤素,烷氧基,醚,酯,酰胺,磺酰基,磺酰胺基,硫醚,氨基甲酸酯,和 喜欢。 本发明化合物能够具有多种用途。 例如,磺酰胺化合物可以起到调节淀粉样蛋白β蛋白的产生的作用,并且可用于预防或治疗各种疾病。 还提供含有本发明化合物的药物组合物。 这样的组合物可广泛用于预防或治疗各种疾病。
-
公开(公告)号:US20120283264A1
公开(公告)日:2012-11-08
申请号:US13287487
申请日:2011-11-02
申请人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
发明人: Andrew P. Degnan , Hong Huang , Lawrence B. Snyder , Fukang Yang , Kevin W. Gillman , Michael F. Parker
IPC分类号: A61K31/421 , C07D413/04 , A61K31/4439 , C07D413/14 , A61K31/444 , C07D413/10 , A61K31/497 , A61K31/506 , A61K31/498 , A61K31/501 , A61P25/18 , A61P25/28 , A61P25/16 , A61P25/30 , A61P25/22 , A61P25/24 , A61P25/08 , A61P1/04 , A61P25/06 , A61P25/00 , C07D263/24
CPC分类号: C07D413/04 , C07D263/18 , C07D413/10 , C07D413/14
摘要: The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
摘要翻译: 本公开内容通常涉及式I化合物,包括其盐,以及使用该化合物的组合物和方法。 这些化合物是mGluR5受体的配体,激动剂和部分激动剂,并且可用于治疗中枢神经系统的各种疾病。
-
-
-
-
-
-
-
-
-